BSE Live
Oct 23, 12:18Prev. Close
2446.75
Open Price
2454.30
Bid Price (Qty.)
2474.70 (10)
Offer Price (Qty.)
2479.05 (20)
NSE Live
Oct 23, 12:18Prev. Close
2445.60
Open Price
2453.50
Bid Price (Qty.)
2477.40 (1)
Offer Price (Qty.)
2477.60 (1)
Cash Flow of Mankind Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
Net Profit/Loss Before Extraordinary Items And Tax | 2,390.36 | 2,259.57 | 1,562.84 | 1,797.54 | 1,440.21 | |
Net CashFlow From Operating Activities | 2,322.16 | 1,982.97 | 1,798.99 | 812.29 | 1,022.33 | |
Net Cash Used In Investing Activities | -12,114.68 | -1,919.12 | -1,040.61 | -1,369.34 | -1,127.16 | |
Net Cash Used From Financing Activities | 9,845.34 | -8.68 | -710.41 | 578.92 | 88.87 | |
Foreign Exchange Gains / Losses | -2.28 | -0.10 | 0.00 | 0.00 | 0.00 | |
Adjustments On Amalgamation Merger Demerger Others | -61.87 | 0.00 | 0.00 | 0.00 | 0.00 | |
Net Inc/Dec In Cash And Cash Equivalents | -11.33 | 55.07 | 47.96 | 21.87 | -15.96 | |
Cash And Cash Equivalents Begin of Year | 211.62 | 134.13 | 86.17 | 22.58 | 77.50 | |
Cash And Cash Equivalents End Of Year | 200.29 | 189.20 | 134.13 | 44.45 | 61.53 |
13.10.2025
19.09.2025
11.09.2025
05.08.2025
01.08.2025
Mankind Pharma Consolidated June 2025 Net Sales at Rs 3,570.35 crore, up 23.4% Y-o-Y
01.08.2025
Mankind Pharma Standalone June 2025 Net Sales at Rs 2,541.36 crore, up 5.75% Y-o-Y
24.06.2025
Mankind Pharma Consolidated March 2025 Net Sales at Rs 3,079.37 crore, up 26.15% Y-o-Y
22.05.2025
Mankind Pharma Consolidated March 2025 Net Sales at Rs 3,079.37 crore, up 26.15% Y-o-Y